Beck Bode LLC’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q4 | – | Sell |
-636
| Closed | -$73K | – | 320 |
|
2020
Q3 | $73K | Buy |
+636
| New | +$73K | 0.03% | 91 |
|
2020
Q2 | – | Sell |
-15,715
| Closed | -$1.69M | – | 55 |
|
2020
Q1 | $1.69M | Sell |
15,715
-10,511
| -40% | -$1.13M | 0.78% | 33 |
|
2019
Q4 | $2.84M | Buy |
26,226
+710
| +3% | +$76.8K | 1.16% | 32 |
|
2019
Q3 | $2.5M | Buy |
25,516
+1,678
| +7% | +$164K | 1.1% | 34 |
|
2019
Q2 | $3.12M | Buy |
23,838
+2,318
| +11% | +$304K | 1.39% | 31 |
|
2019
Q1 | $2.91M | Buy |
21,520
+248
| +1% | +$33.5K | 1.4% | 28 |
|
2018
Q4 | $2.07M | Buy |
+21,272
| New | +$2.07M | 1.13% | 30 |
|